The Journal of Immunology, Vol 152, Issue 10 4749-4757, Copyright © 1994 by American Association of Immunologists

ARTICLES

B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors

D Benjamin, V Sharma, TJ Knobloch, RJ Armitage, MA Dayton and RG Goodwin
Division of Hematology and Oncology, Arthur G. James Cancer Hospital, Columbus, OH.

IL-7 was originally reported as a cytokine produced by stromal cells which supports pre-B cell proliferation in vitro. To determine whether human B cells secrete IL-7 and express IL-7R we studied a wide panel of B cell lines (CLS). In Northern blot analysis we detected 2.4 kb IL-7 mRNA and by quantitative PCR we demonstrated IL-7 expression in 5 of 6 B CLS derived from patients with AIDS-associated Burkitt's lymphoma (AABCL), 3 of 3 CLS derived from patients with American Burkitt's lymphoma and 5 of 6 normal lymphoblastoid CLS. Only 1 of 5 African Burkitt's lymphoma CLS and 2 of 7 EBV- CLS expressed IL-7. A total of 484-bp amplicons was cloned and sequenced and found to correspond to the original IL-7 sequence. Constitutive IL-7 secretion was detected in 5 of 6 AABCL and in 6 of 7 normal lymphoblastoid CLS but in none of the 7 EBV- CLS. IL-7R expression was demonstrated in 8 of 26 CLS, none of which secreted IL-7. Our data suggest that 1) IL-7 mRNA is expressed in malignant B cell phenotypes, which correspond to a narrow window in the B cell differentiation pathway (pre-B, early B, intermediate B), as well as in normal lymphoblastoid B CLS. 2) IL-7 mRNA is expressed in both EBV+ and EBV- CLS, but only the EBV+ CLS secrete IL-7. 3) B cells activated by both EBV and HIV-1 (AABCL) secrete the greatest amount of IL-7. 4) IL-7 autocrine loops are not evident since IL-7R were detected on on CLS, which do not secrete IL-7. Our data provide the first direct evidence of IL-7 secretion by human cells and it is yet to be determined whether IL-7 is secreted by other cell types.

This article has been cited by other articles:

				V. I. Brown, J. Hulitt, J. Fish, C. Sheen, M. Bruno, Q. Xu, M. Carroll, J. Fang, D. Teachey, and S. A. Grupp Thymic Stromal-Derived Lymphopoietin Induces Proliferation of Pre-B Leukemia and Antagonizes mTOR Inhibitors, Suggesting a Role for Interleukin-7R{alpha} Signaling Cancer Res., October 15, 2007; 67(20): 9963 - 9970. [Abstract] [Full Text] [PDF]

				K.-i. Yamanaka, R. Clark, B. Rich, R. Dowgiert, K. Hirahara, D. Hurwitz, M. Shibata, N. Mirchandani, D. A. Jones, D. S. Goddard, et al. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma Blood, March 15, 2006; 107(6): 2440 - 2445. [Abstract] [Full Text] [PDF]

				S. Shulga-Morskoy and B.E. Rich Bioactive IL7-diphtheria fusion toxin secreted by mammalian cells Protein Eng. Des. Sel., January 1, 2005; 18(1): 25 - 31. [Abstract] [Full Text] [PDF]

				V. I. Brown, J. Fang, K. Alcorn, R. Barr, J. M. Kim, R. Wasserman, and S. A. Grupp Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling PNAS, December 9, 2003; 100(25): 15113 - 15118. [Abstract] [Full Text] [PDF]

				B. J. Dezube, M. Zambela, D. R. Sage, J.-F. Wang, and J. D. Fingeroth Characterization of Kaposi sarcoma-associated herpesvirus/human herpesvirus-8 infection of human vascular endothelial cells: early events Blood, July 18, 2002; 100(3): 888 - 896. [Abstract] [Full Text] [PDF]

				T. J. Fry and C. L. Mackall Interleukin-7: from bench to clinic Blood, May 13, 2002; 99(11): 3892 - 3904. [Full Text] [PDF]

				X. He and J. M. Stuart Prostaglandin E2 Selectively Inhibits Human CD4+ T Cells Secreting Low Amounts of Both IL-2 and IL-4 J. Immunol., December 1, 1999; 163(11): 6173 - 6179. [Abstract] [Full Text] [PDF]

				R. G. Hopkins and M. L. Failla Copper Deficiency Reduces Interleukin-2 (IL-2) Production and IL-2 mRNA in Human T-Lymphocytes J. Nutr., February 1, 1997; 127(2): 257 - 262. [Abstract] [Full Text]